Piramal Pharma Limited has informed the Exchange about Transcript
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Piramal Pharma has submitted the transcript of its conference call held on 15th May 2025, which discussed the audited financial results for the quarter and full year ended 31st March 2025. The transcript is available on the company's website under the financial reports section. This is a routine regulatory disclosure under SEBI listing requirements, filed after the earlier intimation dated 29th April 2025. The filing itself does not contain any new financial details or management commentary.
No direct impact on the stock; this is an administrative disclosure that simply makes the call transcript publicly available for investors to review for deeper insights into the company's FY25 performance and management outlook.